Real-world experience from the TRIO network assessing outcomes in patients with chronic hepatitis C treated with elbasvir/grazoprevirin the United States.
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record